Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
PRDX1 overexpression
i
Other names:
PRDX1, Peroxiredoxin 1, Thioredoxin-Dependent Peroxide Reductase 2, Natural Killer Cell-Enhancing Factor A, Proliferation-Associated Gene Protein, Thioredoxin Peroxidase 2, Peroxiredoxin-1, NKEF-A, NKEFA, TDPX2, PAGA, PAGB, PAG, Epididymis Secretory Sperm Binding Protein, Thioredoxin-Dependent Peroxiredoxin 1, Natural Killer-Enhancing Factor A, Proliferation-Associated Gene A, MSP23, PRDX1, PRX1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5052
Related biomarkers:
Fusion
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
PRDX1 overexpression
Cervical Cancer
PRDX1 overexpression
Cervical Cancer
cisplatin
Resistant: C3 – Early Trials
cisplatin
Resistant
:
C3
cisplatin
Resistant: C3 – Early Trials
cisplatin
Resistant
:
C3
PRDX1 overexpression
Hepatocellular Cancer
PRDX1 overexpression
Hepatocellular Cancer
KRAS G12C inhibitor
Sensitive: C3 – Early Trials
KRAS G12C inhibitor
Sensitive
:
C3
KRAS G12C inhibitor
Sensitive: C3 – Early Trials
KRAS G12C inhibitor
Sensitive
:
C3
PRDX1 overexpression
Hepatocellular Cancer
PRDX1 overexpression
Hepatocellular Cancer
GSK525762
Sensitive: C3 – Early Trials
GSK525762
Sensitive
:
C3
GSK525762
Sensitive: C3 – Early Trials
GSK525762
Sensitive
:
C3
PRDX1 overexpression
Hepatocellular Cancer
PRDX1 overexpression
Hepatocellular Cancer
AZD5991
Sensitive: C3 – Early Trials
AZD5991
Sensitive
:
C3
AZD5991
Sensitive: C3 – Early Trials
AZD5991
Sensitive
:
C3
PRDX1 overexpression
Hepatocellular Cancer
PRDX1 overexpression
Hepatocellular Cancer
LY2109761
Sensitive: C3 – Early Trials
LY2109761
Sensitive
:
C3
LY2109761
Sensitive: C3 – Early Trials
LY2109761
Sensitive
:
C3
PRDX1 overexpression
Hepatocellular Cancer
PRDX1 overexpression
Hepatocellular Cancer
GS-9973
Sensitive: C3 – Early Trials
GS-9973
Sensitive
:
C3
GS-9973
Sensitive: C3 – Early Trials
GS-9973
Sensitive
:
C3
PRDX1 overexpression
Hepatocellular Cancer
PRDX1 overexpression
Hepatocellular Cancer
BMS-345541
Sensitive: C3 – Early Trials
BMS-345541
Sensitive
:
C3
BMS-345541
Sensitive: C3 – Early Trials
BMS-345541
Sensitive
:
C3
PRDX1 overexpression
Hepatocellular Cancer
PRDX1 overexpression
Hepatocellular Cancer
AZ 960
Sensitive: C3 – Early Trials
AZ 960
Sensitive
:
C3
AZ 960
Sensitive: C3 – Early Trials
AZ 960
Sensitive
:
C3
PRDX1 overexpression
Hepatocellular Cancer
PRDX1 overexpression
Hepatocellular Cancer
ASP7487
Sensitive: C3 – Early Trials
ASP7487
Sensitive
:
C3
ASP7487
Sensitive: C3 – Early Trials
ASP7487
Sensitive
:
C3
PRDX1 overexpression
Hepatocellular Cancer
PRDX1 overexpression
Hepatocellular Cancer
sorafenib
Sensitive: C3 – Early Trials
sorafenib
Sensitive
:
C3
sorafenib
Sensitive: C3 – Early Trials
sorafenib
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.